These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31727005)

  • 1. Delayed administration of suramin attenuates peritoneal fibrosis in rats.
    Xiong C; Liu N; Shao X; Sharif S; Zou H; Zhuang S
    BMC Nephrol; 2019 Nov; 20(1):411. PubMed ID: 31727005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin inhibits the development and progression of peritoneal fibrosis.
    Xiong C; Liu N; Fang L; Zhuang S; Yan H
    J Pharmacol Exp Ther; 2014 Nov; 351(2):373-82. PubMed ID: 25168661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
    Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
    Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.
    Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S
    J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats.
    Wakabayashi K; Hamada C; Kanda R; Nakano T; Io H; Horikoshi S; Tomino Y
    Perit Dial Int; 2015; 35(5):506-16. PubMed ID: 25292409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats.
    Li L; Shen N; Wang N; Wang W; Tang Q; Du X; Carrero JJ; Wang K; Deng Y; Li Z; Lin H; Wu T
    Kidney Int; 2018 Jun; 93(6):1384-1396. PubMed ID: 29571940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis.
    Ju KD; Kim HJ; Tsogbadrakh B; Lee J; Ryu H; Cho EJ; Hwang YH; Kim K; Yang J; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F342-50. PubMed ID: 26661649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis.
    Li Z; Zhang L; He W; Zhu C; Yang J; Sheng M
    Int J Mol Sci; 2014 Jul; 15(7):12959-71. PubMed ID: 25054320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking core fucosylation of epidermal growth factor (EGF) receptor prevents peritoneal fibrosis progression.
    Yu C; Yang N; Wang W; Du X; Tang Q; Lin H; Li L
    Ren Fail; 2021 Dec; 43(1):869-877. PubMed ID: 33993842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis.
    Wang L; Liu N; Xiong C; Xu L; Shi Y; Qiu A; Zang X; Mao H; Zhuang S
    J Am Soc Nephrol; 2016 Sep; 27(9):2631-44. PubMed ID: 26677863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
    Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
    Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.
    Liu KH; Zhou N; Zou Y; Yang YY; OuYang SX; Liang YM
    Med Sci Monit; 2019 Dec; 25():9346-9356. PubMed ID: 31812978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kampo medicine Daikenchuto inhibits peritoneal fibrosis in mice.
    Kitamura M; Nishino T; Obata Y; Oka S; Abe S; Muta K; Ozono Y; Koji T; Kohno S
    Biol Pharm Bull; 2015; 38(2):193-200. PubMed ID: 25747978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
    Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
    Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
    Su W; Wang H; Feng Z; Sun J
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
    Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
    BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
    Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
    J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model.
    Kunoki S; Tatsukawa H; Sakai Y; Kinashi H; Kariya T; Suzuki Y; Mizuno M; Yamaguchi M; Sasakura H; Ikeno M; Takeuchi K; Ishimoto T; Hitomi K; Ito Y
    Lab Invest; 2023 Apr; 103(4):100050. PubMed ID: 36870292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.
    Hirose M; Nishino T; Obata Y; Nakazawa M; Nakazawa Y; Furusu A; Abe K; Miyazaki M; Koji T; Kohno S
    Perit Dial Int; 2013; 33(2):132-42. PubMed ID: 23032084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.